For research use only. Not for therapeutic Use.
Cetuximab(CAT: M000073) is a chimeric monoclonal antibody targeting the epidermal growth factor receptor (EGFR), a protein that plays a crucial role in cell growth and proliferation. By binding to EGFR, cetuximab inhibits the receptor’s activity, effectively blocking the signaling pathways that promote tumor growth and survival. This mechanism of action makes cetuximab an important therapeutic agent in the treatment of certain cancers, including colorectal cancer and head and neck squamous cell carcinoma.
| Catalog Number | M000073 |
| CAS Number | 205923-56-4 |
| Synonyms | CETUXIMAB;Erbitux;Hsdb 7454;Immunoglobulin G1, anti-(human epidermal growth factor receptor) (human-mouse monoclonal C225 gamma1-chain), disulfide with human-mouse monoclonal C225 kappa-chain, dimer;Unii-pqx0D8J21j;EGFR antibody;IMC 225;CetuxiMab(C22 |
| Molecular Formula | C6484H10042N1732O2023S36 |
| Purity | ≥95% |
| Storage | Room temperature |
